Cyteir Therapeutics Stock Forecast - Accumulation Distribution

Summary

CYTDelisted Stock

USD 2.76 0.01 0.36%

Cyteir Stock Forecast is based on your current time horizon.

On July 7, 2023 Cyteir Therapeutics had Accumulation Distribution of 2612.55. Most investors in Cyteir Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Cyteir Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Cyteir Therapeutics' price structures and extracts relationships that further increase the accuracy of the generated results. The accumulation distribution (A/D) indicator shows the degree to which Cyteir Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Cyteir Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Cyteir Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.

More About Accumulation Distribution All Equity Analysis

Previous Accumulation Distribution	Accumulation Distribution	Trend
3883.87	2612.55

Check Cyteir Therapeutics Volatility

Backtest Cyteir Therapeutics

Trend Details

Next Accumulation Distribution

Cyteir Therapeutics Trading Date Momentum

On July 10 2023 Cyteir Therapeutics was traded for 2.74 at the closing time. Highest Cyteir Therapeutics's price during the trading hours was 2.80 and the lowest price during the day was 2.70 . The net volume was 202.4 K. The overall trading history on the 10th of July contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 0.36% . The overall trading delta to current price is 1.09% .

Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume

Compare Cyteir Therapeutics to competition

View Cyteir Therapeutics Related Equities

Nuvation Bio Magenta Therapeutics Neoleukin Therapeutics Graphite Bio Foghorn Therapeutics C4 Therapeutics Prelude Therapeutics Rezolute Molecular Partners AG MediciNova Anebulo Pharmaceuticals Champions Oncology Eliem Therapeutics HCW Biologics Monte Rosa Therapeutics

Risk & Return

Correlation

Cyteir Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Cyteir Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyteir Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyteir Therapeutics stock market strength indicators, traders can identify Cyteir Therapeutics entry and exit signals to maximize returns.

	Accumulation Distribution	0.0214
	Daily Balance Of Power	0.1667
	Rate Of Daily Change	1.0
	Day Median Price	2.78
	Day Typical Price	2.77
	Market Facilitation Index	0.06
	Price Action Indicator	(0.01)
	Period Momentum Indicator	0.01
	Relative Strength Index	70.56

Cyteir Therapeutics Risk Indicators

The analysis of Cyteir Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cyteir Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cyteir stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

	Mean Deviation	2.76
	Semi Deviation	2.57
	Standard Deviation	5.51
	Variance	30.37
	Downside Variance	12.58
	Semi Variance	6.6
	Expected Short fall	(3.47)

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Cyteir Stock

If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.

	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Global Correlations Find global opportunities by holding instruments from different markets
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Stocks Directory Find actively traded stocks across global markets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC